GraphWear, a company pursuing needle-free approaches to glucose monitoring, has closed a $20.5 million Series B round. This Series B round is a vote of confidence by investors in GraphWear’s approach: to monitor key metrics in the body, like glucose, without breaking the skin at all.  GraphWear Technologies was founded in 2015 by Rajatesh Gudibande … Continue reading GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor